SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Total Non-Current Liabilities | ₹31 Cr | ₹30 Cr | ₹2.65 Cr | ₹0.73 Cr |
What is the latest Total Non-Current Liabilities ratio of SHREE GANESH REMEDIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹31 Cr |
| Mar2024 | ₹30 Cr |
| Mar2020 | ₹2.65 Cr |
| Mar2019 | ₹0.73 Cr |
How is Total Non-Current Liabilities of SHREE GANESH REMEDIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹31 Cr | 1.48 | |
| Mar2024 | ₹30 Cr | 1,037.96 | |
| Mar2020 | ₹2.65 Cr | 264.01 | |
| Mar2019 | ₹0.73 Cr | - | |
Compare Total Non-Current Liabilities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹541.5 Cr | -0.1% | -1% | -38% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -0.1% |
-1% |
-38% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses